Otolaryngology Doctors in Stephenville, TX Accepting Medicare

1 Otolaryngology doctors found. Showing 1 - 1

Dr. Martin Eugene Mcgonagle, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 763 N Graham St, Stephenville, TX 76401 Phone: 254-965-7870    Fax: 254-965-5373

News Archive

ICU risk scores can be repurposed as continuous markers of illness severity

Commonly used ICU risk scores can be "repurposed" as continuous markers of severity of illness in critically ill patients-providing ongoing updates on changes in the patient's condition and risk of death, according to a study in the March issue of Critical Care Medicine, official journal of the Society of Critical Care Medicine. The journal is published by Wolters Kluwer.

Study finds link between dietary sugar and increasing bacterial epidemics

The rising frequency and severity of Clostridium difficile infections may be caused by the commonly used food additive, trehalose, according to Nature.

FDA Advisory Panel recommends approval of Solesta for bowel incontinence

Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration's (FDA) Gastroenterology and Urology Devices Panel recommended approval of Solesta™ as a treatment for fecal (bowel) incontinence, a condition afflicting many Americans, primarily women.

Growing number of countries adopting flexible IP regulations after India issues country's first compulsory license

"A growing number of countries are adopting India's intellectual property regulations, which give enough flexibility to local companies to produce generic versions of popular drugs to safeguard public health," India's Economic Times reports, noting, "In March, India issued the country's first compulsory license, allowing Natco Pharma to legally manufacture and sell a low-cost version of German drugmaker Bayer AG's patented cancer drug, Nexavar, at 3 percent of the original medicine's price on the grounds that Bayer's drug was not meeting public health requirement."

Read more Medical News

› Verified 7 days ago